News

Cullen/Frost Bankers Welcomes New Board Members Amid Changes

Cullen/Frost Bankers Welcomes New Board Members Amid Changes

New Board Members Introduced at Cullen/Frost Bankers

The board of directors of Cullen/Frost Bankers, Inc. (NYSE: CFR) has recently welcomed two new directors, Marsha M. Shields and Jeff Rummel, in an exciting step forward for the organization.

Experience and Insight from New Directors

Marsha M. Shields, who has assumed her role on the board, brings a wealth of knowledge and leadership experience, having served as the CEO and Managing Partner of McCombs Enterprises. Her tenure involves oversight of several core businesses, including the Red McCombs Automotive Group and McCombs Family Partners Ltd. Alongside her prominent positions, Shields also holds a spot as the president of the McCombs Foundation, Inc. Her involvement in various institutions, including the Texas Biomedical Research Institute and the M.D. Anderson Cancer Center, showcases her commitment to making a difference.

Rummel complements Shields' experience with his extensive background in financial services. Before joining the board, he was the managing partner of Ernst & Young's San Antonio office, where he excelled for five years. His expertise in auditing publicly traded companies gives him a unique perspective on risk management, particularly in complex financial environments.

Avery's Retirement Marks a New Chapter

With this addition, there is also a bittersweet moment for the board as Chris Avery announced his retirement after serving since 2015. A respected physician and the former CEO of James Avery Craftsman, Inc., Avery’s contributions have been pivotal during his tenure, particularly during challenging periods like the pandemic. His leadership and dedication have been appreciated by both the board and the wider community.

The Future of Cullen/Frost Bankers

The leadership transition at Cullen/Frost Bankers signifies a broader commitment to enrich the board with diverse expertise as they continue to navigate future challenges. Chairman and CEO Phil Green expressed enthusiasm about the fresh perspectives that Shields and Rummel will bring, highlighting Texas values and extensive business experience.

As Cullen/Frost Bankers continues to grow, this strategic infusion of talent is poised to enhance their capability to adapt and innovate in an evolving financial landscape.

About Cullen/Frost Bankers, Inc.

Cullen/Frost Bankers, Inc. (NYSE: CFR) operates with the vision of delivering comprehensive financial services that include banking, investments, and insurance. As one of the largest banking institutions in the United States, the company manages approximately $53 billion in assets, providing services to regions across Texas. Founded in 1868, Frost has maintained a long-standing commitment to support Texans in fulfilling their financial aspirations.

If you need further information, you can reach out to the Investor Relations team led by AB Mendez at 210-220-5234 or contact Bill Day from Media Relations at 210-220-5427.

Frequently Asked Questions

Who are the new board members of Cullen/Frost Bankers?

The newly appointed members are Marsha M. Shields and Jeff Rummel.

When did Chris Avery announce his retirement?

Chris Avery's retirement was announced as his term is set to expire in April.

What are Marsha Shields' previous roles?

Marsha Shields has been the CEO and Managing Partner of McCombs Enterprises and involved with various foundations and institutes.

What financial services does Cullen/Frost Bankers offer?

The company provides a wide array of services including banking, investments, and insurance to different regions in Texas.

How can I contact Cullen/Frost Bankers for more information?

You can reach the Investor Relations team at 210-220-5234 or Media Relations at 210-220-5427.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading